• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床试验的途径。

Gateways to clinical trials.

作者信息

Tomillero A, Moral M A

出版信息

Methods Find Exp Clin Pharmacol. 2009 Dec;31(10):661-700.

PMID:20140276
Abstract

[Methoxy-(11)C]PD-153035, 2-Methoxyestradiol; Adalimumab, Adecatumumab, Adefovir dipivoxil, ADH-1, ADX-10059, Aflibercept, AIR-human growth hormone, Aliskiren fumarate, AMG-221, Amlodipine besylate/olmesartan medoxomil, Aprepitant; Bavituximab, Bevacizumab, Bexarotene, BIBW-2992, BMS-690514, Bortezomib, Bosentan, Briakinumab; Capecitabine, Certolizumab pegol, Cetuximab, Cholecalciferol, Choline fenofibrate, Chorionic gonadotropin (human), Cixutumumab, Clopidogrel, CP-690550 citrate; Dabigatran, Dacetuzumab, Daclizumab, Dapagliflozin, Darbepoetin alfa, Dasatinib, Denosumab; Efavirenz, Elisidepsin, Enoxaparin, Enzastaurin hydrochloride, Eribulin mesilate, Erlotinib hydrochloride, Everolimus, Exenatide; Fenobam, Figitumumab, Filibuvir, Fondaparinux sodium, Fresolimumab; Gefitinib, Golimumab, Golnerminogene pradenovec; Ifosfamide, Imatinib mesylate, Ipilimumab, Ivabradine hydrochloride, Ixabepilone; Lapatinib ditosylate, Lenalidomide, Levocetirizine dihydrochloride, Liposomal vincristine, Liraglutide; M-118, Masitinib mesylate, Metformin hydrochloride, Micafungin sodium, Moxifloxacin hydrochloride; Neratinib; Oblimersen sodium, Ofatumumab, Olmesartan medoxomil; Paclitaxel nanoparticles, Palifosfamide lysine, Panobacumab, Panobinostat, Patupilone, Peginterferon alfa-2a, Pegylated arginine deiminase 20000, Piclozotan hydrochloride hydrate, Pixantrone maleate, Prasterone, Prasugrel, Prednisone, Progesterone, Prucalopride, pVGI.1 (VEGF-2); Retigabine, rhFSH, Rituximab, Rivaroxaban, Rosuvastatin calcium; Salinosporamide A, Selumetinib, Sipuleucel-T, Somatropin, Sorafenib, SSR-244738, Sunitinib malate; Tamoxifen citrate, Teduglutide, Telavancin hydrochloride, Telmisartan, Telmisartan/amlodipine, Telmisartan/hydrochlorothiazide, Temsirolimus, Tenofovir disoproxil fumarate, Tipifarnib, Tolvaptan, Trastuzumab, Trastuzumab-MCC-DM1, Travoprost, Tremelimumab; Valsartan/amlodipine besylate, Valsartan/amlodipine besylate/hydrochlorothiazide, Valsartan/hydrochlorothiazide, Vandetanib, Vorinostat.

摘要

[甲氧基 -(11)C]PD - 153035、2 - 甲氧基雌二醇;阿达木单抗、阿地卡单抗、阿德福韦酯、ADH - 1、ADX - 10059、阿柏西普、重组人生长激素、阿利吉仑富马酸盐、AMG - 221、苯磺酸氨氯地平/奥美沙坦酯、阿瑞匹坦;巴维昔单抗、贝伐单抗、贝沙罗汀、BIBW - 2992、BMS - 690514、硼替佐米、波生坦、布罗达单抗;卡培他滨、赛妥珠单抗、西妥昔单抗、胆钙化醇、氯贝胆碱、人绒毛膜促性腺激素、西妥昔单抗、氯吡格雷、枸橼酸CP - 690550;达比加群、达西珠单抗、达克珠单抗、达格列净、阿法依泊汀、达沙替尼、地诺单抗;依非韦伦、埃利西地辛、依诺肝素、盐酸恩扎妥林、甲磺酸艾瑞布林、盐酸厄洛替尼、依维莫司、艾塞那肽;非诺班、菲吉图单抗、菲利布韦、磺达肝癸钠、氟雷司珠单抗;吉非替尼、戈利木单抗、戈勒明基因普拉德诺韦克;异环磷酰胺、甲磺酸伊马替尼、伊匹木单抗、盐酸伊伐布雷定、伊沙匹隆;拉帕替尼二对甲苯磺酸盐、来那度胺、盐酸左西替利嗪、脂质体长春新碱、利拉鲁肽;M - 118、甲磺酸马西替尼、盐酸二甲双胍、米卡芬净钠、盐酸莫西沙星;奈拉替尼;奥布利默森钠、奥法木单抗、奥美沙坦酯;紫杉醇纳米粒、帕利磷酰胺赖氨酸、帕诺巴单抗、帕诺比司他、帕图匹隆、聚乙二醇化干扰素α - 2a、聚乙二醇化精氨酸脱亚氨酶20000、盐酸匹克洛唑坦水合物、马来酸匹杉琼、普拉睾酮、普拉格雷、泼尼松、孕酮、普芦卡必利、pVGI.1(VEGF - 2);瑞替加滨、重组促卵泡激素、利妥昔单抗、利伐沙班、瑞舒伐他汀钙;盐孢菌素A、司美替尼、西普列克、生长激素、索拉非尼、SSR - 244738、苹果酸舒尼替尼;枸橼酸他莫昔芬、替度鲁肽、盐酸特拉万星、替米沙坦、替米沙坦/氨氯地平、替米沙坦/氢氯噻嗪、替西罗莫司、替诺福韦酯富马酸盐、替匹法尼、托伐普坦、曲妥珠单抗、曲妥珠单抗 - MCC - DM1、曲伏前列素、曲美木单抗;缬沙坦/苯磺酸氨氯地平、缬沙坦/苯磺酸氨氯地平/氢氯噻嗪、缬沙坦/氢氯噻嗪、凡德他尼、伏立诺他

相似文献

1
Gateways to clinical trials.临床试验的途径。
Methods Find Exp Clin Pharmacol. 2009 Dec;31(10):661-700.
2
Gateways to clinical trials.临床试验的途径。
Methods Find Exp Clin Pharmacol. 2009 Apr;31(3):183-226.
3
Gateways to clinical trials.
Methods Find Exp Clin Pharmacol. 2009 Nov;31(9):597-633.
4
Gateways to clinical trials.临床试验的途径。
Methods Find Exp Clin Pharmacol. 2007 Sep;29(7):467-509.
5
Gateways to clinical trials.
Methods Find Exp Clin Pharmacol. 2010 Jun;32(5):331-88. doi: 10.1358/mf.2010.32.5.1520420.
6
Gateways to clinical trials.临床试验的途径。
Methods Find Exp Clin Pharmacol. 2005 Jun;27(5):331-72.
7
Gateways to clinical trials.临床试验的途径
Methods Find Exp Clin Pharmacol. 2007 Nov;29(9):625-55.
8
Gateways to clinical trials.临床试验的途径。
Methods Find Exp Clin Pharmacol. 2008 Sep;30(7):543-88.
9
Gateways to clinical trials.临床试验的途径
Methods Find Exp Clin Pharmacol. 2010 May;32(4):247-88. doi: 10.1358/mf.2010.32.4.1507200.
10
Gateways to clinical trials.临床试验的途径。
Methods Find Exp Clin Pharmacol. 2009 Sep;31(7):463-93.

引用本文的文献

1
The Major Heat Shock Proteins, Hsp70 and Hsp90, in 2-Methoxyestradiol-Mediated Osteosarcoma Cell Death Model.2-甲氧基雌二醇介导的骨肉瘤细胞死亡模型中的主要热休克蛋白 Hsp70 和 Hsp90。
Int J Mol Sci. 2020 Jan 17;21(2):616. doi: 10.3390/ijms21020616.
2
Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential.用于脑肿瘤成像及治疗潜力的磷脂酰丝氨酸靶向纳米诊疗剂
Mol Imaging. 2017 Jan 1;16:1536012117708722. doi: 10.1177/1536012117708722.
3
Histone deacetylase inhibitors and pancreatic cancer: are there any promising clinical trials?
组蛋白去乙酰化酶抑制剂与胰腺癌:有哪些有前途的临床试验?
World J Gastroenterol. 2013 Feb 28;19(8):1173-81. doi: 10.3748/wjg.v19.i8.1173.
4
EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer.EGCG 通过抑制 STAT3 信号通路增强吉西他滨和 CP690550 对人胰腺癌的治疗潜力。
PLoS One. 2012;7(2):e31067. doi: 10.1371/journal.pone.0031067. Epub 2012 Feb 13.